Commentary to "Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials" (Galvano et al. J Bone Oncol 2019; 18:100252).
Détails
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_4DEC0E9E3BD0
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
Titre
Commentary to "Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials" (Galvano et al. J Bone Oncol 2019; 18:100252).
Périodique
Journal of bone oncology
ISSN
2212-1366 (Print)
ISSN-L
2212-1366
Statut éditorial
Publié
Date de publication
06/2020
Peer-reviewed
Oui
Volume
22
Pages
100294
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Pubmed
Web of science
Open Access
Oui
Création de la notice
13/08/2020 8:37
Dernière modification de la notice
21/11/2022 9:22
Données d'usage
